1-6 of 6
Jeffrey Carter
Close
Sort by
Journal Articles

Accelerating the Adoption of New and Emerging Therapies for DLBCL: A Community-Based Quality Improvement Initiative

Peter A. Riedell, Ellie Moses-Okwei, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen
Journal: Blood
Blood (2023) 142 (Supplement 1): 7264.
https://doi.org/10.1182/blood-2023-173686
Published: 2023
Journal Articles

Optimizing the Integration of Genetic Testing in AML Care in Community Practice: Insights from a Quality Improvement Initiative

Catherine Lai, Adam Bagg, Lindsay Gurska, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen
Journal: Blood
Blood (2023) 142 (Supplement 1): 7277.
https://doi.org/10.1182/blood-2023-172976
Published: 2023
Journal Articles

Advancing Collaboration across the Multiple Myeloma Treatment Journey from Oncology Clinic to CAR T-Cell Center: A Paired Center Transformative Quality Improvement Initiative

Sikander Ailawadhi, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen
Journal: Blood
Blood (2023) 142 (Supplement 1): 5074.
https://doi.org/10.1182/blood-2023-173042
Published: 2023
Journal Articles

Key Findings from a Transformative Quality Improvement Initiative on Advancing CAR T-Cell Treatment in Non-Hodgkin Lymphoma

Manali K. Kamdar, Ellie Moses-Okwei, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen
Journal: Blood
Blood (2023) 142 (Supplement 1): 3705.
https://doi.org/10.1182/blood-2023-173681
Published: 2023
Journal Articles

Advancing Care of Patients with Sickle Cell Disease through a Transformative Quality Improvement Initiative

Biree Andemariam, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen
Journal: Blood
Blood (2023) 142 (Supplement 1): 7224.
https://doi.org/10.1182/blood-2023-173457
Published: 2023
Journal Articles

Optimizing Management of AML: Insights from a Community-Based Quality Improvement Initiative

Joshua F. Zeidner, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen
Journal: Blood
Blood (2023) 142 (Supplement 1): 7278.
https://doi.org/10.1182/blood-2023-173038
Published: 2023